Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) Non Operating Income (2016 - 2025)

Fortress Biotech has reported Non Operating Income over the past 12 years, most recently at -$1.4 million for Q4 2025.

  • Quarterly results put Non Operating Income at -$1.4 million for Q4 2025, up 33.58% from a year ago — trailing twelve months through Dec 2025 was $11.8 million (up 463.42% YoY), and the annual figure for FY2025 was $36.7 million, up 460.94%.
  • Non Operating Income for Q4 2025 was -$1.4 million at Fortress Biotech, down from $15.7 million in the prior quarter.
  • Over the last five years, Non Operating Income for FBIO hit a ceiling of $18.5 million in Q2 2021 and a floor of -$6.0 million in Q4 2021.
  • Median Non Operating Income over the past 5 years was $338500.0 (2023), compared with a mean of $2.0 million.
  • Biggest five-year swings in Non Operating Income: tumbled 252.8% in 2021 and later skyrocketed 1362.56% in 2025.
  • Fortress Biotech's Non Operating Income stood at -$6.0 million in 2021, then soared by 245.06% to $8.8 million in 2022, then tumbled by 115.47% to -$1.4 million in 2023, then tumbled by 58.35% to -$2.1 million in 2024, then surged by 33.58% to -$1.4 million in 2025.
  • The last three reported values for Non Operating Income were -$1.4 million (Q4 2025), $15.7 million (Q3 2025), and -$62000.0 (Q2 2025) per Business Quant data.